ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $382 | -47.7% | 34,175 | 0.0% | 0.06% | -46.7% |
| Q2 2023 | $731 | -47.1% | 34,175 | 0.0% | 0.12% | -49.4% |
| Q1 2023 | $1,382 | -17.9% | 34,175 | -5.6% | 0.24% | -23.5% |
| Q4 2022 | $1,684 | -99.9% | 36,205 | 0.0% | 0.31% | -17.6% |
| Q3 2022 | $1,878,000 | -17.4% | 36,205 | -24.7% | 0.38% | -13.8% |
| Q2 2022 | $2,274,000 | -40.1% | 48,110 | -9.8% | 0.44% | -33.0% |
| Q1 2022 | $3,798,000 | -33.1% | 53,360 | -29.7% | 0.65% | -31.2% |
| Q4 2021 | $5,673,000 | +59.4% | 75,869 | +21.1% | 0.95% | +43.8% |
| Q3 2021 | $3,558,000 | – | 62,635 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |